Cargando…
Molecular Modeling and In Vitro Studies of a Neutral Oxime as a Potential Reactivator for Acetylcholinesterase Inhibited by Paraoxon
The present work aimed to compare the small, neutral and monoaromatic oxime, isatin-3-oxime (isatin-O), to the commercial ones, pralidoxime (2-PAM) and obidoxime, in a search for a new potential reactivator for acetylcholinesterase (AChE) inhibited by the pesticide paraoxon (AChE/POX) as well as a n...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278417/ https://www.ncbi.nlm.nih.gov/pubmed/30424582 http://dx.doi.org/10.3390/molecules23112954 |
_version_ | 1783378361190449152 |
---|---|
author | de Paula, Reuel L. de Almeida, Joyce S. F. D. Cavalcante, Samir F. A. Gonçalves, Arlan S. Simas, Alessandro B. C. Franca, Tanos C. C. Valis, Martin Kuca, Kamil Nepovimova, Eugenie Granjeiro, José M. |
author_facet | de Paula, Reuel L. de Almeida, Joyce S. F. D. Cavalcante, Samir F. A. Gonçalves, Arlan S. Simas, Alessandro B. C. Franca, Tanos C. C. Valis, Martin Kuca, Kamil Nepovimova, Eugenie Granjeiro, José M. |
author_sort | de Paula, Reuel L. |
collection | PubMed |
description | The present work aimed to compare the small, neutral and monoaromatic oxime, isatin-3-oxime (isatin-O), to the commercial ones, pralidoxime (2-PAM) and obidoxime, in a search for a new potential reactivator for acetylcholinesterase (AChE) inhibited by the pesticide paraoxon (AChE/POX) as well as a novel potential scaffold for further synthetic modifications. The multicriteria decision methods (MCDM) allowed the identification of the best docking poses of those molecules inside AChE/POX for further molecular dynamic (MD) studies, while Ellman’s modified method enabled in vitro inhibition and reactivation assays. In corroboration with the theoretical studies, our experimental results showed that isatin-O have a reactivation potential capable of overcoming 2-PAM at the initial moments of the assay. Despite not achieving better results than obidoxime, this molecule is promising for being an active neutral oxime with capacity of crossing the blood–brain barrier (BBB), to reactivate AChE/POX inside the central and peripheral nervous systems. Moreover, the fact that isatin-O can also act as anticonvulsant makes this molecule a possible multipotent reactivator. Besides, the MCDM method showed to be an accurate method for the selection of the best docking poses generated in the docking studies. |
format | Online Article Text |
id | pubmed-6278417 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62784172018-12-13 Molecular Modeling and In Vitro Studies of a Neutral Oxime as a Potential Reactivator for Acetylcholinesterase Inhibited by Paraoxon de Paula, Reuel L. de Almeida, Joyce S. F. D. Cavalcante, Samir F. A. Gonçalves, Arlan S. Simas, Alessandro B. C. Franca, Tanos C. C. Valis, Martin Kuca, Kamil Nepovimova, Eugenie Granjeiro, José M. Molecules Article The present work aimed to compare the small, neutral and monoaromatic oxime, isatin-3-oxime (isatin-O), to the commercial ones, pralidoxime (2-PAM) and obidoxime, in a search for a new potential reactivator for acetylcholinesterase (AChE) inhibited by the pesticide paraoxon (AChE/POX) as well as a novel potential scaffold for further synthetic modifications. The multicriteria decision methods (MCDM) allowed the identification of the best docking poses of those molecules inside AChE/POX for further molecular dynamic (MD) studies, while Ellman’s modified method enabled in vitro inhibition and reactivation assays. In corroboration with the theoretical studies, our experimental results showed that isatin-O have a reactivation potential capable of overcoming 2-PAM at the initial moments of the assay. Despite not achieving better results than obidoxime, this molecule is promising for being an active neutral oxime with capacity of crossing the blood–brain barrier (BBB), to reactivate AChE/POX inside the central and peripheral nervous systems. Moreover, the fact that isatin-O can also act as anticonvulsant makes this molecule a possible multipotent reactivator. Besides, the MCDM method showed to be an accurate method for the selection of the best docking poses generated in the docking studies. MDPI 2018-11-12 /pmc/articles/PMC6278417/ /pubmed/30424582 http://dx.doi.org/10.3390/molecules23112954 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article de Paula, Reuel L. de Almeida, Joyce S. F. D. Cavalcante, Samir F. A. Gonçalves, Arlan S. Simas, Alessandro B. C. Franca, Tanos C. C. Valis, Martin Kuca, Kamil Nepovimova, Eugenie Granjeiro, José M. Molecular Modeling and In Vitro Studies of a Neutral Oxime as a Potential Reactivator for Acetylcholinesterase Inhibited by Paraoxon |
title | Molecular Modeling and In Vitro Studies of a Neutral Oxime as a Potential Reactivator for Acetylcholinesterase Inhibited by Paraoxon |
title_full | Molecular Modeling and In Vitro Studies of a Neutral Oxime as a Potential Reactivator for Acetylcholinesterase Inhibited by Paraoxon |
title_fullStr | Molecular Modeling and In Vitro Studies of a Neutral Oxime as a Potential Reactivator for Acetylcholinesterase Inhibited by Paraoxon |
title_full_unstemmed | Molecular Modeling and In Vitro Studies of a Neutral Oxime as a Potential Reactivator for Acetylcholinesterase Inhibited by Paraoxon |
title_short | Molecular Modeling and In Vitro Studies of a Neutral Oxime as a Potential Reactivator for Acetylcholinesterase Inhibited by Paraoxon |
title_sort | molecular modeling and in vitro studies of a neutral oxime as a potential reactivator for acetylcholinesterase inhibited by paraoxon |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278417/ https://www.ncbi.nlm.nih.gov/pubmed/30424582 http://dx.doi.org/10.3390/molecules23112954 |
work_keys_str_mv | AT depaulareuell molecularmodelingandinvitrostudiesofaneutraloximeasapotentialreactivatorforacetylcholinesteraseinhibitedbyparaoxon AT dealmeidajoycesfd molecularmodelingandinvitrostudiesofaneutraloximeasapotentialreactivatorforacetylcholinesteraseinhibitedbyparaoxon AT cavalcantesamirfa molecularmodelingandinvitrostudiesofaneutraloximeasapotentialreactivatorforacetylcholinesteraseinhibitedbyparaoxon AT goncalvesarlans molecularmodelingandinvitrostudiesofaneutraloximeasapotentialreactivatorforacetylcholinesteraseinhibitedbyparaoxon AT simasalessandrobc molecularmodelingandinvitrostudiesofaneutraloximeasapotentialreactivatorforacetylcholinesteraseinhibitedbyparaoxon AT francatanoscc molecularmodelingandinvitrostudiesofaneutraloximeasapotentialreactivatorforacetylcholinesteraseinhibitedbyparaoxon AT valismartin molecularmodelingandinvitrostudiesofaneutraloximeasapotentialreactivatorforacetylcholinesteraseinhibitedbyparaoxon AT kucakamil molecularmodelingandinvitrostudiesofaneutraloximeasapotentialreactivatorforacetylcholinesteraseinhibitedbyparaoxon AT nepovimovaeugenie molecularmodelingandinvitrostudiesofaneutraloximeasapotentialreactivatorforacetylcholinesteraseinhibitedbyparaoxon AT granjeirojosem molecularmodelingandinvitrostudiesofaneutraloximeasapotentialreactivatorforacetylcholinesteraseinhibitedbyparaoxon |